reference/26884193

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26884193

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	257
issn	1120-8694
issueIdentifier	4
pageRange	251-257
publicationName	Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
startingPage	251
bibliographicCitation	Li BS, Gong HY, Huang W, Yi Y, Zhang ZC, Li HS, Wang ZT, Yu JM. Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and pemetrexed, cisplatin for locally advanced esophageal squamous cell carcinoma. Dis Esophagus. 2011 May;24(4):251–7. doi: 10.1111/j.1442-2050.2010.01130.x. PMID: 21073623.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0dd59b640d159c02487b8c05c61d0a5a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f17dfd9a1dd0330d503605bd957c3d4a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e33c91d58b2d213527aeaf48ee3f158c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5579cad12ac4a2936ebbd3194e279825 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1351ac8f560c3c1114566454fa06e4b9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b3c40b682f6f24828793674a6ab0d0b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c677f2124baa357745f9b4f6f782ad1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98abf8f15307b5d25fa15617d1feac38
date	2010-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/21073623 https://doi.org/10.1111/j.1442-2050.2010.01130.x
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20541 https://portal.issn.org/resource/ISSN/1120-8694
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and pemetrexed, cisplatin for locally advanced esophageal squamous cell carcinoma
discusses	http://id.nlm.nih.gov/mesh/M0227083 http://id.nlm.nih.gov/mesh/M0009376 http://id.nlm.nih.gov/mesh/M0009679 http://id.nlm.nih.gov/mesh/M0004505
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D005971Q000008 http://id.nlm.nih.gov/mesh/D004938Q000532 http://id.nlm.nih.gov/mesh/D050397Q000379 http://id.nlm.nih.gov/mesh/D018307Q000532 http://id.nlm.nih.gov/mesh/D006147Q000031 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D002945Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D002945Q000009 http://id.nlm.nih.gov/mesh/D000068437 http://id.nlm.nih.gov/mesh/D006147Q000008 http://id.nlm.nih.gov/mesh/D003131 http://id.nlm.nih.gov/mesh/D004938Q000188 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D005971Q000009 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D008198Q000528 http://id.nlm.nih.gov/mesh/D019583 http://id.nlm.nih.gov/mesh/D018307Q000188 http://id.nlm.nih.gov/mesh/D006147Q000009 http://id.nlm.nih.gov/mesh/D050397Q000009 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D004947Q000473 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000971Q000494 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6658

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129439837 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851

Total number of triples: 66.